ContraVir
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ContraVir and buy or sell other stocks, ETFs, and their options commission-free!About CTRV
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
CEOKaouthar Lbiati, MD
CEOKaouthar Lbiati, MD
Employees—
Employees—
HeadquartersMorristown, New Jersey
HeadquartersMorristown, New Jersey
Founded2013
Founded2013
Employees—
Employees—
CTRV Key Statistics
Market cap801.80K
Market cap801.80K
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume12.55K
Average volume12.55K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$36.73
52 Week high$36.73
52 Week low$0.033
52 Week low$0.033
Stock Snapshot
The current ContraVir(CTRV) stock price is $3.33, with a market capitalization of 801.8K. The stock trades at a price-to-earnings (P/E) ratio of -0.01.
ContraVir(CTRV) stock opened on 2025-12-13 at —. The price climbed to — and dipped to —.
ContraVir(CTRV) shares are trading with a volume of 0, against a daily average of 12.55K.
During the past year, ContraVir(CTRV) stock moved between $0.03 at its lowest and $36.73 at its peak.
During the past year, ContraVir(CTRV) stock moved between $0.03 at its lowest and $36.73 at its peak.